Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Florance-XT
- Development stage
- Unknown
- Lead developer
- Emblazon Life Sciences
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Florance-XT is a branded hematinic pharmaceutical formulation marketed by Emblazon Life Sciences. It is a combination product typically containing Ferrous Ascorbate and Folic Acid. Ferrous ascorbate is a synthetic coordination complex of iron and ascorbic acid; the ascorbic acid component maintains the iron in the highly bioavailable ferrous (Fe2+) state and enhances its absorption in the gastrointestinal tract. Folic acid (Vitamin B9) is an essential nutrient required for DNA synthesis, amino acid metabolism, and the proper maturation of red blood cells. Florance-XT is primarily indicated for the treatment and prevention of iron deficiency anemia, folate deficiency, and nutritional anemias, and it is widely used as a supplement during pregnancy and lactation to support maternal health and fetal development.
- Brand names
- Florance-XTFlorance-XT-Emblaze
- Other names
- Ferrous Ascorbate and Folic Acid Tablets
02
Targets
DHFR (Dihydrofolate reductase)
Beyond the preview
Go deeper on Florance-XT.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Florance-XT.